Cell, Gene And Specialty Drug Costs Intensify For Health Plans

Cell, Gene And Specialty Drug Costs Intensify For Health Plans
Specialty drugs are an increasing worry for health plans and employers as new and innovative therapies enter the U.S. market and patients flock to them.